Mitelos and New Mark to market Otiblock® in the Arab Emirates

Mitelos, CataloniaBio member that develops, registers and manufactures medical devices and dietary supplements, and New Mark Medicine agree to market the therapeutic alternative for treating impacted ear wax Otiblock® in the United Arab Emirates and Saudi Arabia. The product is already sold in the Spanish market since September of 2016.

Otiblock® spray helps to remove impacted ear wax from the ear canal thanks to its formulation, which is oil-free and helps the ear to maintain the proper pH. In addition to its cerumenolytic action, the product benefits patients with associated risk factors that make them more prone to otitis externa, such as those with dermatological conditions (eczema, psoriasis, seborrheic dermatitis, etc.) and immunosuppression, and users of headphones and hearing aids.  

More information is available on the Mitelos website

 

Comments


To comment, please login or create an account
Modify cookies